Biologic competition, biosimilar status, and IRA timing
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
All licensed biological products with biosimilar competition tracking, interchangeability status, orphan exclusivity, and reference product linkage. IRA 11-year clock pre-calculated.
Request context access
Ask us to provision this analytical context into your BigQuery or Snowflake workspace.
Request AccessRelated context
Overview
Regulatory teams use this context to reconstruct product history without parsing authority-specific files.
All licensed biological products with biosimilar competition tracking, interchangeability status, orphan exclusivity, and reference product linkage. IRA 11-year clock pre-calculated.
Analyze approval, label, safety, REMS, biologic, small molecule, and NDC records without source-specific parsing work.
Join NDA, BLA, NDC, RxCUI, UNII, SPL set ID, patent, and exclusivity identifiers through the drug identity spine.
Model regulatory timelines, indication expansion, label change velocity, and eligibility clocks with curated fields.
Trace every normalized attribute back to the official FDA or NLM source authority.
Source authority
FDA Purple Book
Freshness
Last refreshed 2026-09-01
Monthly
Coverage
4K+ products
2 delivery tables